Cite
HARVARD Citation
Stein, J. et al. (2019). Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of response. Annals of oncology. pp. 589-596. [Online].